All posts by: Michael Zand

About Michael Zand

What’s Hot in Cancer Immunotherapy 2017: The Photos – Xconomy

Continue reading

2017-06-26 NEWS

Xconomy

What’s Hot in Cancer Immunotherapy 2017: The Photos
Xconomy
Xconomy’s cancer immunotherapy event on June 14th in Seattle brought a packed house to The Pelton Auditorium on the campus of the Fred Hutchinson Cancer Research Center. Attendees heard top executives, physicians, researchers, investors and …
Cancer Research Institute Awards $1 Million to Fund the Development of Innovative Microchip-Based Research …Newswise (press release)

all 2 news articles »

Continue reading

2017-06-26 NEWS

Huntington’s disease in mice partly reversed using CRISPR
BioNews
Eliminating the faulty protein that causes Huntington’s disease goes some way to reversing disease progression in mice, a study has found. Scientists used the genome editing technique CRISPR/Cas9 to ‘switch off’ the disease-causing gene in mice brains, …

Continue reading

2017-06-26 NEWS

Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast …
Business Wire (press release)
Immunotherapy stimulates the body’s own immune system to fight tumor cells. HIFU, which has already demonstrated its efficacy in the treatment of malignant and benign tumors, could have a major impact on the efficacy of immunotherapy when delivered as …